These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22396775)

  • 1. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.
    Wagner S; Zensi A; Wien SL; Tschickardt SE; Maier W; Vogel T; Worek F; Pietrzik CU; Kreuter J; von Briesen H
    PLoS One; 2012; 7(3):e32568. PubMed ID: 22396775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
    Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
    J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
    Wünsch A; Mulac D; Langer K
    Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
    Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
    J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells.
    Raudszus B; Mulac D; Langer K
    Int J Pharm; 2018 Jan; 536(1):211-221. PubMed ID: 29175342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
    Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
    Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
    Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
    J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells.
    Tamaru M; Akita H; Kajimoto K; Sato Y; Hatakeyama H; Harashima H
    Int J Pharm; 2014 Apr; 465(1-2):77-82. PubMed ID: 24530390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.
    Kim HR; Andrieux K; Gil S; Taverna M; Chacun H; Desmaële D; Taran F; Georgin D; Couvreur P
    Biomacromolecules; 2007 Mar; 8(3):793-9. PubMed ID: 17309294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.
    Neves AR; Queiroz JF; Lima SAC; Reis S
    Bioconjug Chem; 2017 Apr; 28(4):995-1004. PubMed ID: 28355061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
    Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
    Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopeptide-based micellar and liposomal carriers: Influence of surface charge and particle size on cellular uptake into blood brain barrier cells.
    Sydow K; Nikolenko H; Lorenz D; Müller RH; Dathe M
    Eur J Pharm Biopharm; 2016 Dec; 109():130-139. PubMed ID: 27702684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
    Kuo YC; Rajesh R
    Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
    Cramer S; Rempe R; Galla HJ
    Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.